Chemosensitization of Pancreatic Cancer by Inhibition of the 26S Proteasome
Authors:
- Richard J. BoldRBRichard J. Bold
- Subbulakshi VirudachalamSVSubbulakshi Virudachalam
- David J. McConkeyDMDavid J. McConkey
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 100 (1) , 11-17
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Pathway of Neuronal Apoptosis Induced by Hypoxia/ReoxygenationJournal of Neurochemistry, 2000
- Gemcitabine-Induced Programmed Cell Death (Apoptosis) of Human Pancreatic Carcinoma Is Determined by Bcl-2 ContentAnnals of Surgical Oncology, 1999
- The ubiquitin-proteasome pathway in cancerBritish Journal of Cancer, 1998
- Programmed cell death and the proteasomeApoptosis, 1998
- Proteasome-Dependent Regulation of p21WAF1/CIP1ExpressionBiochemical and Biophysical Research Communications, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.Genes & Development, 1995
- Structure-Function Analysis of Bcl-2 ProteinJournal of Biological Chemistry, 1995
- The ubiquitin-proteasome proteolytic pathwayCell, 1994
- Pancreatic cancer: the greatest oncological challengeBMJ, 1988